Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-19-206929
Filing Date
2019-07-30
Accepted
2019-07-30 15:07:59
Documents
75
Period of Report
2019-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d761557d10k.htm 10-K 1064620
2 EX-21 d761557dex21.htm EX-21 10929
3 EX-23 d761557dex23.htm EX-23 1661
4 EX-24 d761557dex24.htm EX-24 11936
5 EX-31.1 d761557dex311.htm EX-31.1 10471
6 EX-31.2 d761557dex312.htm EX-31.2 10498
7 EX-32 d761557dex32.htm EX-32 5212
14 GRAPHIC g761557g75u36.jpg GRAPHIC 32586
  Complete submission text file 0001193125-19-206929.txt   12316380

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT neog-20190531.xml EX-101.INS 4332568
9 XBRL TAXONOMY EXTENSION SCHEMA neog-20190531.xsd EX-101.SCH 50400
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20190531_cal.xml EX-101.CAL 46483
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20190531_def.xml EX-101.DEF 394901
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20190531_lab.xml EX-101.LAB 481154
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20190531_pre.xml EX-101.PRE 439186
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-17988 | Film No.: 19984942
SIC: 2835 In Vitro & In Vivo Diagnostic Substances